Cargando…

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018

Detalles Bibliográficos
Autores principales:	Rosenblum, Hannah G., Lewis, Rayleen M., Gargano, Julia W., Querec, Troy D., Unger, Elizabeth R., Markowitz, Lauri E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993559/ https://www.ncbi.nlm.nih.gov/pubmed/33764964 http://dx.doi.org/10.15585/mmwr.mm7012a2

Ejemplares similares

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Meites, Elissa, et al.
Publicado: (2019)

Human papillomavirus prevalence in male and female university students in Gaborone, Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010()
por: Petrosky, Emiko Y., et al.
Publicado: (2015)

962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016
por: Gargano, Julia, et al.
Publicado: (2019)

Randomization Modeling to Ascertain Clustering Patterns of Human Papillomavirus Types Detected in Cervicovaginal Samples in the United States
por: Querec, Troy David, et al.
Publicado: (2013)

HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
por: McClung, Nancy, et al.
Publicado: (2022)

Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity
por: Brady, Allison M., et al.
Publicado: (2020)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
por: Walker, Tanja Y., et al.
Publicado: (2019)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

CDC Activities for Improving Implementation of Human Papillomavirus Vaccination, Cervical Cancer Screening, and Surveillance Worldwide
por: Senkomago, Virginia, et al.
Publicado: (2017)

Human Papillomavirus–Attributable Cancers — United States, 2012–2016
por: Senkomago, Virginia, et al.
Publicado: (2019)

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022
por: Hancuh, Molly, et al.
Publicado: (2023)

Global Routine Vaccination Coverage, 2018
por: Peck, Megan, et al.
Publicado: (2019)

Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
por: Van Dyne, Elizabeth A., et al.
Publicado: (2018)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017
por: Arana, Jorge, et al.
Publicado: (2018)

Human Papillomavirus Prevalence in Oropharyngeal Cancer before Vaccine Introduction, United States
por: Steinau, Martin, et al.
Publicado: (2014)

Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination
por: Shing, Jaimie Z., et al.
Publicado: (2019)

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
por: Gargano, Julia W., et al.
Publicado: (2021)

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
por: Stokley, Shannon, et al.
Publicado: (2013)

Status of New Vaccine Introduction — Worldwide, 2016–2021
por: Kaur, Gurpreet, et al.
Publicado: (2023)

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
por: Jit, Mark
Publicado: (2021)

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States
por: Stokley, Shannon, et al.
Publicado: (2014)

Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
por: Zhao, Dan, et al.
Publicado: (2017)

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
por: Hesse, Elisabeth M., et al.
Publicado: (2019)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
por: Jorba, Jaume, et al.
Publicado: (2018)

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
por: Rosenblum, Hannah G., et al.
Publicado: (2021)

Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2018–19 School Year
por: Seither, Ranee, et al.
Publicado: (2019)

Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women — United States, 2008 and 2016
por: McClung, Nancy M., et al.
Publicado: (2019)

Assessment of human papillomavirus vaccination rates of adolescents in California, 2018–2019
por: Warren, Brooke R., et al.
Publicado: (2023)

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019
por: Jorba, Jaume, et al.
Publicado: (2019)

Timing of Introduction of Complementary Foods — United States, 2016–2018
por: Chiang, Katelyn V., et al.
Publicado: (2020)

826. HIV Infection and HPV Genotype Patterns among Young Women with Advanced Cervical Neoplasia in Davidson County, Tennessee
por: Giffin, Leahanne, et al.
Publicado: (2021)

Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction
por: Nickel, Brooke, et al.
Publicado: (2017)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction ()
por: Li, Anyie J., et al.
Publicado: (2022)

Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic — United States, 2020
por: Hong, Kai, et al.
Publicado: (2021)

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
por: Mesher, David, et al.
Publicado: (2016)

Stemming the Wave of Cervical Cancer: Human Papillomavirus Vaccine Introduction in India
por: Mehrotra, Ravi, et al.
Publicado: (2017)

Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018
por: Kahn, Katherine E., et al.
Publicado: (2018)

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses — Worldwide, July 2018–December 2019
por: Macklin, Grace, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nj50cbheistcl1uafd2rhmi107